MS
Morgan Stanley
MS has lower modeled downside risk, despite its lower overall score.
OPBK
OP Bancorp
OPBK has a slight edge over MS overall, supported by stronger valuation and stronger fundamentals.
MS Fundamentals
| Metric | Status |
|---|---|
| Healthy | |
| Strong | |
| N/A | |
| N/A |
MS's revenue and profitability are currently healthy. Free cash flow and net leverage aren't meaningful measures for financial services companies like MS.
OPBK Fundamentals
| Metric | Status |
|---|---|
| Healthy | |
| Strong | |
| N/A | |
| N/A |
OPBK's revenue and profitability are currently healthy. Free cash flow and net leverage aren't meaningful measures for financial services companies like OPBK.
MS PE Valuation
| Level | PE | Price | Vs current |
|---|---|---|---|
| Cheap | 11x | $134 | -29% |
| Fair | 14x | $178 | -5.7% |
| Forward | 14x | $189 | — |
| Current | 15x | $189 | — |
| Expensive | 18x | $223 | +18% |
Historical ranges are pointers, not guarantees.
MS's PE is in its fair range at 15x. If earnings grow as analysts expect, today's price would be 14x next year's earnings.
OPBK PE Valuation
| Level | PE | Price | Vs current |
|---|---|---|---|
| Cheap | 5.2x | $10.47 | -30% |
| Forward | 7.3x | $14.96 | — |
| Current | 7.4x | $14.96 | — |
| Fair | 7.9x | $15.97 | +6.8% |
| Expensive | 9.6x | $19.38 | +30% |
Historical ranges are pointers, not guarantees.
OPBK has the edge over MS in the historical PE scenario, which offers more potential upside but is not a forecast.
MS Forward outlook
| Metric | Outlook |
|---|---|
| Improving | |
| Growth | |
| Growth | |
| Improving | |
| Limited | |
| Moderate |
MS has the edge over OPBK on the outlook, with more favorable valuation expectations.
OPBK Forward outlook
| Metric | Outlook |
|---|---|
| Stable | |
| Growth | |
| Growth | |
| Improving | |
| Limited | |
| High |
Analysts expect earnings and revenue growth for OPBK, with profitability improving.
MS Earnings Per Share
| Quarter | TTM EPS | YoY |
|---|---|---|
| Forward | $13.39 | +6.3% |
| Q3 2026 | $12.60 | +29% |
| Q2 2026 | $12.37 | +40% |
| Q1 2026 | $11.04 | +29% |
| Q4 2025 | $10.21 | +28% |
| Q3 2025 | $9.76 | +48% |
| Q2 2025 | $8.84 | +45% |
| Q1 2025 | $8.53 | +55% |
| Q4 2024 | $7.95 | +53% |
MS has the edge over OPBK on earnings, with more consistent year-over-year improvement.
OPBK Earnings Per Share
| Quarter | TTM EPS | YoY |
|---|---|---|
| Forward | $2.05 | +2% |
| Q3 2026 | $2.01 | +28% |
| Q2 2026 | $1.94 | +31% |
| Q1 2026 | $1.83 | +29% |
| Q4 2025 | $1.72 | +24% |
| Q3 2025 | $1.57 | +11% |
| Q2 2025 | $1.48 | +7.2% |
| Q1 2025 | $1.42 | +0.7% |
| Q4 2024 | $1.39 | -10% |
OPBK earned $2.01 per share over the past year, up 28% from the year before.
MS Quarterly Revenue
| Quarter | Revenue | YoY |
|---|---|---|
| Q3 2026 | $20.3B | +12% |
| Q2 2026 | $21.3B | +27% |
| Q1 2026 | $20.6B | +16% |
| Q4 2025 | $17.9B | +10% |
| Q3 2025 | $18.2B | +18% |
| Q2 2025 | $16.8B | +12% |
| Q1 2025 | $17.7B | +17% |
| Q4 2024 | $16.2B | +26% |
MS has the edge over OPBK on sales, with stronger typical year-over-year growth.
| Quarter | Margin | YoY |
|---|---|---|
| Q3 2026 | 32% | -1.2 points |
| Q2 2026 | 34% | +6.9 points |
| Q1 2026 | 34% | +2.8 points |
| Q4 2025 | 32% | +2 points |
| Q3 2025 | 33% | +5.6 points |
| Q2 2025 | 28% | +0.4 points |
| Q1 2025 | 31% | +2.2 points |
| Q4 2024 | 30% | +14 points |
MS's operating margin was 32% last quarter, down 1.2 points from the same quarter a year ago.
OPBK Quarterly Revenue
| Quarter | Revenue | YoY |
|---|---|---|
| Q3 2026 | $27.5M | +12% |
| Q2 2026 | $25.7M | +8.6% |
| Q1 2026 | $24.6M | +10% |
| Q4 2025 | $24.3M | +14% |
| Q3 2025 | $24.5M | +18% |
| Q2 2025 | $23.7M | +16% |
| Q1 2025 | $22.2M | +14% |
| Q4 2024 | $21.3M | +7.2% |
OPBK's revenue has grown year over year for nine quarters in a row: $28M last quarter, up 12% from the same quarter a year ago.
| Quarter | Margin | YoY |
|---|---|---|
| Q3 2026 | 38% | -1.7 points |
| Q2 2026 | 43% | +7.3 points |
| Q1 2026 | 40% | +5.8 points |
| Q4 2025 | 39% | +8 points |
| Q3 2025 | 40% | +3 points |
| Q2 2025 | 36% | -1.5 points |
| Q1 2025 | 35% | -2.6 points |
| Q4 2024 | 31% | -5.4 points |
OPBK has the edge over MS on profitability, with a higher operating margin.
MS Free Cash Flow
| Quarter | Free cash flow | YoY |
|---|---|---|
| Q3 2026 | -$46B | -$42.7B |
| Q2 2026 | -$2.7B | -123% |
| Q1 2026 | -$7.1B | +$16.9B |
| Q4 2025 | -$2.4B | -120% |
| Q3 2025 | -$3.3B | +$14B |
| Q2 2025 | $11.8B | +368% |
| Q1 2025 | -$24B | -650% |
| Q4 2024 | $11.8B | +$29.6B |
MS's free cash flow was −$58.3B over the past year, against −$3.7B the year before. Free cash flow isn't a meaningful measure for financial services companies like MS.
OPBK Free Cash Flow
| Quarter | Free cash flow | YoY |
|---|---|---|
| Q3 2026 | $25.2M | +7.6% |
| Q2 2026 | -$7.4M | +$266K |
| Q1 2026 | $7.6M | +80% |
| Q4 2025 | $3.5M | -23% |
| Q3 2025 | $23.4M | +83% |
| Q2 2025 | -$7.7M | -149% |
| Q1 2025 | $4.2M | +$7.5M |
| Q4 2024 | $4.5M | +$6M |
OPBK has the edge over MS on cash generation, producing positive trailing cash flow while its opponent burns cash.
MS Total Shares
| Period | Change % | Net change |
|---|---|---|
| Quarterly | -0.2% | -3M shares |
| 1 year | -1.5% | -24M shares |
| 3 years | -4.7% | -77M shares |
| 5 years | -14% | -246M shares |
| Available history | -4.5% | -74M shares |
MS has the edge over OPBK on shareholder dilution, with a more favorable share count trend.
OPBK Total Shares
| Period | Change % | Net change |
|---|---|---|
| Quarterly | +0.1% | +13.9K shares |
| 1 year | +0.2% | +36.5K shares |
| 3 years | -1.2% | -185K shares |
| 5 years | -1.6% | -245K shares |
| Available history | -6.1% | -979K shares |
OPBK has 15M diluted shares, about the same as a year ago.
| Quarter | Spent |
|---|---|
| Q3 2026 | — |
| Q4 2025 | $7,000 |
| Q3 2025 | — |
| Q2 2025 | $713,000 |
| Q1 2025 | — |
| Q4 2024 | — |
| Q3 2024 | $52,000 |
| Q2 2024 | $2.2M |
MS Net Leverage
| Quarter | Net Leverage | Status |
|---|---|---|
| Q3 2026 | 7.8x | High |
| Q2 2026 | 7.3x | High |
| Q1 2026 | 8.2x | High |
| Q4 2025 | 8.6x | High |
| Q3 2025 | 8.4x | High |
| Q2 2025 | 8.7x | High |
| Q1 2025 | 8.7x | High |
| Q4 2024 | 7.9x | High |
MS's net debt is about 7.8 years of its operating earnings (EBITDA), down from 8.4 years a year ago. Net leverage isn't a meaningful measure for financial services companies like MS.
OPBK Net Leverage
| Quarter | Net Leverage | Status |
|---|---|---|
| Q3 2026 | -3.0x | Net Cash |
| Q2 2026 | -1.5x | Net Cash |
| Q1 2026 | -1.3x | Net Cash |
| Q4 2025 | -1.6x | Net Cash |
| Q3 2025 | -2.4x | Net Cash |
| Q2 2025 | -4.9x | Net Cash |
| Q1 2025 | -4.0x | Net Cash |
| Q4 2024 | -1.3x | Net Cash |
OPBK has the edge over MS on leverage, with a lower net debt burden relative to earnings.
MS Weekly Momentum
| Metric | Value | Status |
|---|---|---|
| RSI | 45.0 | Neutral |
| Stochastic | 18.7 | Oversold |
MS's weekly RSI is 45 (neutral) and its Stochastic is 19 (oversold).
OPBK Weekly Momentum
| Metric | Value | Status |
|---|---|---|
| RSI | 51.1 | Neutral |
| Stochastic | 26.6 | Neutral |
OPBK's weekly RSI is 51 (neutral) and its Stochastic is 27 (neutral).
MS PE vs Financial Services Sector
| Metric | MS | Sector median | Relative |
|---|---|---|---|
| PE | 15x | 13x | 15% above |
| PE % | 59 | 63 | 4 pts below |
MS is trading at 15x earnings, a 15% premium to the Financial Services sector's median of 13x.
OPBK PE vs Financial Services Sector
| Metric | OPBK | Sector median | Relative |
|---|---|---|---|
| PE | 7.4x | 13x | 43% below |
| PE % | 42 | 63 | 21 pts below |
OPBK has the edge over MS on valuation relative to its sector.
MS Weekly Moving Averages
| Moving average | MA price | Relative |
|---|---|---|
| 8 week MA | $186.5 | 1.5% above |
| 20 week MA | $203.3 | 6.9% below |
| 50 week MA | $191.9 | 1.4% below |
| 100 week MA | $164.9 | 15% above |
| 200 week MA | $129.3 | 46% above |
MS's trend is mixed: it's above three of its five weekly moving averages, and 46% above its 200-week average.
OPBK Weekly Moving Averages
| Moving average | MA price | Relative |
|---|---|---|
| 8 week MA | $15.0 | 0.1% below |
| 20 week MA | $15.2 | 1.6% below |
| 50 week MA | $14.5 | 3.1% above |
| 100 week MA | $13.9 | 7.3% above |
| 200 week MA | $12.3 | 22% above |
OPBK has pulled back, but its long-term trend is still up: it's below its 8- and 20-week averages, but 22% above its 200-week average.
MS Yearly ROI
| Year | Start price | End price | ROI |
|---|---|---|---|
| 2020 | $51.1 | $68.1 | +33% |
| 2021 | $68.1 | $99.3 | +46% |
| 2022 | $99.3 | $86.1 | -13% |
| 2023 | $86.1 | $93.3 | +8.3% |
| 2024 | $93.3 | $126.8 | +36% |
| 2025 | $126.8 | $181.9 | +43% |
| 2026 YTD | $181.9 | $189.2 | +4% |
MS has finished higher in five of the last six years. It's up 4% so far in 2026.
OPBK Yearly ROI
| Year | Start price | End price | ROI |
|---|---|---|---|
| 2020 | $10.2 | $7.38 | -28% |
| 2021 | $7.38 | $12.5 | +70% |
| 2022 | $12.5 | $11.3 | -9.7% |
| 2023 | $11.3 | $11.0 | -3.1% |
| 2024 | $11.0 | $15.6 | +42% |
| 2025 | $15.6 | $14.3 | -8.4% |
| 2026 YTD | $14.3 | $15.0 | +4.9% |
OPBK has the edge over MS on returns for 2026, with the stronger performance.